People · Operator
Named in public records as an officer, director or promoter · active 2008–2021 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Leap Therapeutics, Inc. | — | Pharmaceuticals | Series C | $105.1M | $1.1B | 2017 |
| Vaxinnate Corp | — | Biotechnology | Series B | $92.6M | $128.9M | 2009 |
| Catalyst Biosciences Inc | — | Biotechnology | Series C | $65.3M | $77.4M | 2008 |
| Stemgent, Inc. | — | Biotechnology | Series A | $37.9M | $408.5M | 2011 |
| Globeimmune Inc | — | Pharmaceuticals | Series B | $28.0M | $71.4M | 2009 |
| Mosaic Biosciences, Inc. | — | Biotechnology | Series A | $14.7M | $176.1M | 2011 |
| GITR Inc. | — | Pharmaceuticals | Seed | $8.3M | $57.1M | 2011 |
| Painreform Ltd. | — | Biotechnology | Series A | $6.0M | $155.8M | 2021 |
Augustine Lawlor at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Augustine Lawlor on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.